'Black Box Warning' Counters Levaquin Claims, Judge Says

Law360, New York (June 21, 2013, 4:00 PM ET) -- Johnson & Johnson adequately warned a Levaquin user that the antibiotic is linked to tendon tears, a New Jersey judge ruled, rejecting the man's contention that a so-called black box warning failed because it did not compare Levaquin's risks to those of similar drugs.

Judge Carol Higbee granted summary judgment to Johnson & Johnson on June 17 in a suit in multicounty litigation over tendon injuries allegedly caused by Levaquin. The drugmaker is also facing federal multidistrict litigation in Minnesota over the claims, although a substantial...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required